We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.
APEN

Delisted

APEN was delisted on the 3rd of April, 2023.

Back to rankings

35 hedge funds and large institutions have $29.7M invested in Apollo Endosurgery, Inc. in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 38 → 35 (-3)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

54% less capital invested

Capital invested by funds: $64.4M → $29.7M (-$34.7M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
7
Increased
8
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$2.81M
2
GS
Gagnon Securities
New York
+$2.43M
3
GA
Gagnon Advisors
New York
+$1.33M
4
Goldman Sachs
Goldman Sachs
New York
+$593K
5
WVP
Worth Venture Partners
New Jersey
+$281K

Top Sellers

Rank Fund Capital Flow
1
CAM
Cortina Asset Management
Wisconsin
-$3.97M
2
SCM
Stonepine Capital Management
Oregon
-$1.94M
3
ACM
Athyrium Capital Management
New York
-$1.81M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.47M
5
MHP
Manatuck Hill Partners
Connecticut
-$769K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$5K +$6.79K +1,375 New
RWA
27
Ropes Wealth Advisors
Massachusetts
$4K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$4K +$2.4K +486 +89%
JP Morgan Chase
29
JP Morgan Chase
New York
$2K -$286K -57,827 -99%
VFA
30
Valeo Financial Advisors
Indiana
$1K +$997 +202 +105%
RE
31
RBC Europe
United Kingdom
$3 – – –
CAM
32
Cortina Asset Management
Wisconsin
– -$3.97M -553,766 Closed
ACM
33
Athyrium Capital Management
New York
– -$1.81M -252,079 Closed
MHP
34
Manatuck Hill Partners
Connecticut
– -$769K -107,190 Closed
MAG
35
Millrace Asset Group
Pennsylvania
– -$710K -99,035 Closed
EI
36
EAM Investors
California
– -$626K -87,279 Closed
PCM
37
Prelude Capital Management
New York
– -$4K -600 Closed
Wells Fargo
38
Wells Fargo
California
– -$1.98K -400 -99%
AIC
39
Ameritas Investment Company
Nebraska
– +$30 +6 New
LPC
40
Loeb Partners Corp
New York
– +$138 +28 New
1
2

APEN Hedge Fund Activity: Q4 2018 in Review

35 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2018, worth a combined $29.7M — down 54% from $64.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of APEN and 7 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 8 added.

The largest buyer was Nantahala Capital Management, adding an estimated $2.81M. The largest seller was Cortina Asset Management, exiting entirely with an estimated $3.97M sold.

  • 35 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2018, down from 38 in Q3 2018.
  • Funds reported $29.7M of Apollo Endosurgery, Inc. stock for Q4 2018, down 54% quarter-over-quarter.
  • 7 funds opened new Apollo Endosurgery, Inc. positions in Q4 2018 and 8 closed out, a net change of -1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2018 was Nantahala Capital Management, an estimated $2.81M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2018 was Cortina Asset Management, an estimated $3.97M sold.

Based on aggregated 13F filings for Q4 2018.